AssistRx last week introduced a new technology that simplifies the prescribing of specialty therapies while streamlining communications between prescribers, pharmacies, patients and manufacturers. It’s smart technology that can lead to patients receiving specialty medications weeks earlier than ever before, the company claimed.
The Biotechnology Industry Organization and the Delaware BioScience Association last week commended the Delaware State Senate for passing legislation designed to create a pathway for the substitution of interchangeable biologic medicines.
Dietary supplement use by U.S. adults is more prevalent than indicated by published data from the National Health and Nutrition Examination Surveys, according to a new article in the peer-reviewed Journal of the American College of Nutrition.
The National Retail Federation has announced that it is moving forward with the creation of a program that will provide retailers access to information on cybersecurity threats identified by retailers, government and law enforcement agencies, as well as partners in the financial services sector.
Pfizer Consumer Healthcare on Monday teamed up with actor and active volunteer Josh Duhamel for the Advil Relief in Action campaign, which features the #ReliefinAction Pledge on Facebook and a Mobile Relief Center tour making approximately 100 stops throughout the country.
QS/1, a provider of healthcare automation solutions, announced the introduction of the Motion SlateMate tablet, a wireless device that is available for use with QS/1's pharmacy management systems and point-of-sale platforms.
Warmer spring weather spurred continued consumer spending and activity this March. According to the National Retail Federation, March retail sales — which exclude automobiles, gas stations and restaurants — increased 0.8% adjusted month-to-month and 1.6% unadjusted year-over-year.
Now available online, the Drug Enforcement Administration National Prescription Drug Take-Back Day collection site locator allows consumers to search for a nearby location to dispose of unneeded medications on Saturday, April 26, 2014, the National Association of Boards of Pharmacy announced Wednesday.
Mylan on Friday confirmed that a federal district court has granted its request to enforce a settlement agreement between Endo Pharmaceuticals and Mylan settling patent litigation in connection with Mylan's filing of an abbreviated new drug application with the Food and Drug Administration for frovatriptan succinate tablets, 2.5 mg.